Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta. Biomembranes|December 29, 2016
Role of the H-bond between L53 and T56 for Aquaporin-4 epitope in Neuromyelitis OpticaFrancesco Pisani, Laura Simone, Concetta Domenica Gargano, et al.
Journal of Cellular Physiology|July 1, 2024
RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cellsMariangela Centrone, Ilaria Saltarella, Mariagrazia D'Agostino, et al.
Clinical Drug Investigation|August 14, 2021
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2-3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre ExperienceGiammarco Milella, Alessandro Introna, Eustachio D'Errico, et al.
Journal of Neurology|August 18, 2018
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosisAntonio Scarafino, Eustachio D'Errico, Alessandro Introna, et al.
The Journal of Biological Chemistry|September 21, 2014
Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodiesFrancesco Pisani, Maria Grazia Mola, Laura Simone, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 10, 2020
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosisPaola Pierucci, Nicolino Ambrosino, Michela Dimitri, et al.
Journal of Neurology|November 22, 2015
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP)Rosanna Tortelli, Massimiliano Copetti, Simona Arcuti, et al.
HIV Research & Clinical Practice|January 31, 2025
Impacts of a multipronged initiative with community HIV clinics to support retention and re-engagement in HIV careEllen Eaton, Claudia T Martorell, Jewel Sawyer, et al.
Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiativeBabette S Edgar, Adam S Cheifetz, Simon M Helfgott, et al.
BMJ Open|March 27, 2020
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)Paolina Salamone, Giuseppe Fuda, Federico Casale, et al.
Pageof 8